Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Fomsgaard

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 7, 2007
Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individualsMette Thorn, Sheila Tang, Dominic Therrien, et al.
Ticks and Tick-Borne Diseases|June 2, 2019
Field samplings of Ixodes ricinus ticks from a tick-borne encephalitis virus micro-focus in Northern Zealand, DenmarkAndreas Petersen, Maiken Worsøe Rosenstierne, Morten Rasmussen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 6, 2019
Opposite effects of Vaccinia and modified Vaccinia Ankara on trained immunityBastiaan A Blok, Kristoffer J Jensen, Peter Aaby, et al.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|April 15, 2021
Possible Involvement of Central Nervous System in COVID-19 and Sequence Variability of SARS-CoV-2 Revealed in Autopsy Tissue Samples: A Case ReportLis Høy Marbjerg, Christina Jacobsen, Jannik Fonager, et al.
Vaccine|July 20, 2011
Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01Anders Fomsgaard, Ingrid Karlsson, Gregers Gram, et al.
Plos One|May 22, 2013
Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvantKaren S Korsholm, Ingrid Karlsson, Sheila T Tang, et al.
AIDS Research and Human Retroviruses|July 4, 2012
Identification of conserved subdominant HIV Type 1 CD8(+) T Cell epitopes restricted within common HLA Supertypes for therapeutic HIV Type 1 vaccinesIngrid Karlsson, Henrik Kløverpris, Kristoffer Jarlov Jensen, et al.
Clinical Immunology (Orlando, Fla.)|January 15, 2013
Adjuvanted HLA-supertype restricted subdominant peptides induce new T-cell immunity during untreated HIV-1-infectionIngrid Karlsson, Lea Brandt, Lasse Vinner, et al.
Plos One|October 2, 2015
Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T CellsSanne Skov Jensen, Anders Fomsgaard, Tine Kochendorf Larsen, et al.
Vaccine|October 10, 2020
Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret modelKate Guilfoyle, Diane Major, Sarah Skeldon, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 7, 2007
Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individualsMette Thorn, Sheila Tang, Dominic Therrien, et al.
Ticks and Tick-Borne Diseases|June 2, 2019
Field samplings of Ixodes ricinus ticks from a tick-borne encephalitis virus micro-focus in Northern Zealand, DenmarkAndreas Petersen, Maiken Worsøe Rosenstierne, Morten Rasmussen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 6, 2019
Opposite effects of Vaccinia and modified Vaccinia Ankara on trained immunityBastiaan A Blok, Kristoffer J Jensen, Peter Aaby, et al.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|April 15, 2021
Possible Involvement of Central Nervous System in COVID-19 and Sequence Variability of SARS-CoV-2 Revealed in Autopsy Tissue Samples: A Case ReportLis Høy Marbjerg, Christina Jacobsen, Jannik Fonager, et al.
Vaccine|July 20, 2011
Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01Anders Fomsgaard, Ingrid Karlsson, Gregers Gram, et al.
Plos One|May 22, 2013
Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvantKaren S Korsholm, Ingrid Karlsson, Sheila T Tang, et al.
AIDS Research and Human Retroviruses|July 4, 2012
Identification of conserved subdominant HIV Type 1 CD8(+) T Cell epitopes restricted within common HLA Supertypes for therapeutic HIV Type 1 vaccinesIngrid Karlsson, Henrik Kløverpris, Kristoffer Jarlov Jensen, et al.
Clinical Immunology (Orlando, Fla.)|January 15, 2013
Adjuvanted HLA-supertype restricted subdominant peptides induce new T-cell immunity during untreated HIV-1-infectionIngrid Karlsson, Lea Brandt, Lasse Vinner, et al.
Plos One|October 2, 2015
Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T CellsSanne Skov Jensen, Anders Fomsgaard, Tine Kochendorf Larsen, et al.
Vaccine|October 10, 2020
Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret modelKate Guilfoyle, Diane Major, Sarah Skeldon, et al.
Pageof 12